Adverse health outcomes and health-related quality of life (HRQoL) among long-term adolescent and young adult (AYA) brain tumour survivors: results from the population-based SURVAYA study
Authors:
- Konstantinos AngoumisKAKonstantinos Angoumis
- Catarina S. PadillaCPCatarina S. Padilla
- Mathilde C. M. KouwenhovenMKMathilde C. M. Kouwenhoven
- Rhodé M. BijlsmaRhodé M. Bijlsma
- Suzanne E. J. KaalSKSuzanne E. J. Kaal
- Monique E. M. M. BosMBMonique E. M. M. Bos
- Tom van der HulleTHTom van der Hulle
- Martinus P. G. BroenMBMartinus P. G. Broen
- Janine NuverJNJanine Nuver
- Winette T. A. van der GraafWinette T. A. van der Graaf
- Sophie PaugeSPSophie Pauge
Open Access
- 14 January 2025
- journal article
- research article
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 33 (2) , 1-13
Abstract
Purpose: Adolescent and young adult (AYA) malignant brain tumour (BT) survivors are at risk of adverse health outcomes, which may impact their health-related quality of life (HRQoL). This study aimed to investigate the (1) prevalence of physical and psychological adverse health outcomes, (2) the HRQoL, and (3) the association of adverse health outcomes and HRQoL among long-term AYA-BT survivors. Adverse health outcomes and HRQoL were compared to other AYA cancer (AYAC) survivors. Methods: A cross-sectional secondary data analysis of the SURVAYA study among 133 AYA-BT and 3877 AYAC survivors was conducted. Participant self-reported adverse health outcomes and HRQoL scores were analysed and compared between the two populations. Associations with HRQoL were assessed using linear regression modelling with AIC-based backward elimination. Results: AYA-BT survivors faced significant issues of fatigue (47.6%), future uncertainty (45.2%), and medical conditions like vision (34.4%), speech, taste, or smell (26.2%) impairments, cancer recurrence, and metastasis (25.4%). Neurocognitive symptoms were identified as BT-specific issues (13.6–33.6%). Compared to AYAC survivors, AYA-BT survivors reported significantly (p < 0.05) lower functioning scores on the role, cognitive, emotional, and social HRQoL, with cognitive (56.0%) and emotional (40.0%) domains being the most affected. Adverse health outcomes were negatively associated with HRQoL, ranging from small to large clinical relevance. Conclusion: Long-term AYA-BT survivors were identified as a highly burdened population, affected by multifaceted issues and multidimensional detriments in HRQoL years beyond their cancer diagnosis. This study highlights the necessity of long-term follow-up and a holistic, multidisciplinary approach to survivorship care to ultimately improve the quality of AYA-BT survivorship.Keywords
This publication has 44 references indexed in Scilit:
- Quality of life in long-term and very long-term cancer survivors versus population controls in GermanyActa Oncologica, 2017
- Primary brain tumor patients’ supportive care needs and multidisciplinary rehabilitation, community and psychosocial support services: awareness, referral and utilizationJournal of Neuro-Oncology, 2015
- Survival of adults with primary malignant brain tumours in Europe; Results of the EUROCARE-5 studyEuropean Journal of Cancer, 2015
- Occurrence and predictors of the fatigue in high-grade glioma patientsNeurological Sciences, 2015
- Taste and smell dysfunction in childhood cancer survivorsAppetite, 2014
- Gender-specific quality of life after cancer in young adulthood: a comparison with the general populationQuality of Life Research, 2013
- A New Reality: Long-Term Survivorship With a Malignant Brain TumorOncology Nursing Forum, 2013
- Neurocognitive and sociodemographic functioning of glioblastoma long-term survivorsJournal of Neuro-Oncology, 2012
- Evidence-Based Guidelines for Determination of Sample Size and Interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30Journal of Clinical Oncology, 2011
- Strengthening the Reporting of Observational Studies in Epidemiology (STROBE)Epidemiology, 2007